Critical appraisal of AMSTAR: Challenges, limitations, and potential solutions from the perspective of an assessor

BMC Medical Research Methodology

Volumn 15, Issue 1, 2015, Pages

  Faggion, Clovis Mariano ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

AMSTAR checklist; Clinical evidence; Methods; Systematic review

Indexed keywords

EVIDENCE BASED MEDICINE; HUMAN; LITERATURE; MEDICAL RESEARCH; PROCEDURES; QUALITY CONTROL; QUESTIONNAIRE; REPRODUCIBILITY; STANDARDS; TOTAL QUALITY MANAGEMENT;

BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; REVIEW LITERATURE AS TOPIC; SURVEYS AND QUESTIONNAIRES; TOTAL QUALITY MANAGEMENT;

EID: 84938912376     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/s12874-015-0062-6     Document Type: Short Survey

References (14)

1. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.
2. AMSTAR. Assessing the Methodological Quality of Systematic Reviews. http://amstar.ca/. Acessed 26 March 2015.
3. Farrington DP. Methodological quality standards for evaluation research. Ann Am Acad Polit Soc Sci. 2003;1:49-68.
4. Kung J, Chiappelli F, Cajulis OO, Avezova R, Kossan G, Chew L, et al. From systematic reviews to clinical recommendations for evidence-based health care: validation of Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) for grading of clinical relevance. Open Dent J. 2010;4:84-91.
5. Pieper D, Buechter RB, Li L, Prediger B, Eikermann M. Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties. J Clin Epidemiol. 2015;68:574-83.
6. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
7. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
8. Halladay CW, Trikalinos TA, Schmid IT, Schmid CH, Dahabreh IJ. Using data sources beyond PubMed has a modest impact on the results of systematic reviews of therapeutic interventions. J Clin Epidemiol. 2015; http://dx.doi.org/10.1016/j.jclinepi.2014.12.017
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
10. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
11. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J ClinEpidemiol. 2011;64:383-94.
12. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Going from evidence to recommendations. BMJ. 2008;336:1049-51.
13. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from
14. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.